Hotel Leela has support at Rs 35: Gujral

Published on Thu, Sep 17, 2009 at 09:44 |  Source : CNBC-TV18

Updated at Thu, Sep 17, 2009 at 17:09  

22207 Investors following Hotel Leela. Share this News with them.
0
0
Share on Tumblr
Ashwani Gujral, Technical Analyst

Excerpts from Bazaar on CNBC-TV18 Watch the full show ยป

ALSO READ

Hotel Leela Venture has support at Rs 35 and it can go back to RS 43, says Technical Analyst, Ashwani Gujral .

Gujral told CNBC-TV18, "There are several stocks, which have broken out. EIH has been in a range of Rs 100-146, so getting towards the higher end of the range. Hotel Leela has support at Rs 35; it could get up to Rs 43 and even Rs 55. Now money is moving into stocks, which haven't moved, so hotels had not moved really in this entire rally. Indian Hotels could get up to levels of Rs 85 and even smaller ones Royal Orchid also moved up and that could get up to Rs 85-90."

He further added, "Now all of these double digit type counters are likely to run-up above 5,000-5,100 on the Nifty. People are sort of calling 5,000-5,100 as a top but anecdotally there is hardly any evidence of frenzy or the kind of behaviour that you see from retail ahead of intermediate tops, so people could be wrong by about 10% here and you could find yourself at Rs 5,500-5,600 rather than 5,100 by the time this rally is over."

  

More on Moneycontrol

Trending News

Business News

Government to directly check BBM and other IM services
Competition ahoy: Monkey 1, Sensex in neck-and-neck race "Competition ahoy: Monkey 1, Sensex in neck-and-neck race"

From DJ Greek Fin Min Says Feb 17 Final Day For Greek Bond Exchange Offer

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 11 2012, 11:52 | Source: CNBC-TV18

TCS to expand centers in N.America; CY12 focus on Japan  

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com